Evidence map›Paper›PMID 32153695›Full record

ArticleThe Pan African medical journal2019

[Sulfadoxine-pyrimethamine-based intermittent preventive treatment in pregnant women and its effect on birth weight: application of 3-dosing regimen in the urban area of South Benin in 2017].

Chabi Olaniran Alphonse Biaou, Alphonse Kpozehouen, Yolaine Glèlè-Ahanhanzo, Gloria Ayivi-Vinz, Abdou-Rahim Ouro-Koura, Colette Azandjèmé

Abstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chabi Olaniran Alphonse BiaouDépartement d'Epidémiologie et de Biostatistiques, Institut Régional de Santé Publique, Université d'Abomey-Calavi, Bénin.
Alphonse KpozehouenDépartement d'Epidémiologie et de Biostatistiques, Institut Régional de Santé Publique, Université d'Abomey-Calavi, Bénin.
Yolaine Glèlè-AhanhanzoDépartement d'Epidémiologie et de Biostatistiques, Institut Régional de Santé Publique, Université d'Abomey-Calavi, Bénin.
Gloria Ayivi-VinzDépartement d'Epidémiologie et de Biostatistiques, Institut Régional de Santé Publique, Université d'Abomey-Calavi, Bénin.
Abdou-Rahim Ouro-KouraCentre de Formation en Santé Publique, Lomé, Togo.
Colette AzandjèméDépartement de Promotion de la Santé, Institut Régional de Santé Publique, Université d'Abomey-Calavi, Bénin.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMalaria is a major public health problem, responsible for many complications during pregnancy including inadequate intra-uterine growth and hypotrophies. The aim of this study was to determine the adherence to the 3 doses of sulfadoxine-pyrimethamine-based intermittent preventive treatment (IPT) on birthweight in the Cotonou health zone II and III.

methodsWe conducted a cross-sectional study focusing on 630 women in the postpartum period residing in the Cotonou health zone II and III and selected using a two stage sample. Data were collected through a questionnaire and a data processing form. For analysis, data were weighted and we used variance analysis to compare means and to compare proportions with Chi-square Test including estimates regarding the strength of the association by odds ratio (OR) and confidence interval at 95%.

resultsAdherence to the 3 doses of sulfadoxine-pyrimethamine-based intermittent preventive treatment was 34.08% (CI95%: 24.84% 43.30%]. A significant birthweight-gain of 264.5 g (p < 0.001) in mothers who had received more than 3 doses of sulfadoxine-pyrimethamine-based intermittent preventive treatment and chances of having low birth weight baby was lower (OR = 0.45; p = 0.001) among these mothers compared to those who had received less than 3 doses of sulfadoxine pyrimethamine.

conclusionThis study highlights low adherence to the new 3-dose regimen of sulfadoxine-pyrimethamine-based intermittent preventive treatment in the Cotonou health zone II and III, but it reflects its potential to contribute to the reduction of the risk of low birth weight. Strategies must therefore be implemented to strengthen its application for prevention of malaria and of its consequences on vulnerable targets.

Indexed as

AdultAntimalarialsBeninBirth WeightCross-Sectional StudiesDrug CombinationsFemaleHumansInfant, Low Birth WeightInfant, NewbornMalariaMaleMedication AdherencePregnancyPregnancy Complications, ParasiticPyrimethamineAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineBeninlow birth weightMalariapregnancyprevention and control

Identifiers

PMID32153695
PMCPMC7046103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.